S&P 500   4,282.47 (+0.20%)
DOW   33,954.79 (-0.08%)
QQQ   330.28 (+0.54%)
AAPL   174.55 (+0.00%)
MSFT   291.53 (+0.07%)
META   175.62 (+0.44%)
GOOGL   120.68 (+0.95%)
AMZN   142.43 (+0.23%)
TSLA   916.90 (+0.54%)
NVDA   188.34 (+2.72%)
NIO   19.98 (-0.50%)
BABA   90.67 (+1.00%)
AMD   100.67 (+2.44%)
MU   63.07 (+2.35%)
T   18.46 (+0.22%)
CGC   3.85 (-5.17%)
F   16.04 (+0.06%)
GE   79.49 (-0.54%)
DIS   122.88 (+0.06%)
AMC   20.04 (-6.18%)
PYPL   99.10 (-0.32%)
PFE   48.95 (-0.65%)
NFLX   245.63 (+1.86%)
S&P 500   4,282.47 (+0.20%)
DOW   33,954.79 (-0.08%)
QQQ   330.28 (+0.54%)
AAPL   174.55 (+0.00%)
MSFT   291.53 (+0.07%)
META   175.62 (+0.44%)
GOOGL   120.68 (+0.95%)
AMZN   142.43 (+0.23%)
TSLA   916.90 (+0.54%)
NVDA   188.34 (+2.72%)
NIO   19.98 (-0.50%)
BABA   90.67 (+1.00%)
AMD   100.67 (+2.44%)
MU   63.07 (+2.35%)
T   18.46 (+0.22%)
CGC   3.85 (-5.17%)
F   16.04 (+0.06%)
GE   79.49 (-0.54%)
DIS   122.88 (+0.06%)
AMC   20.04 (-6.18%)
PYPL   99.10 (-0.32%)
PFE   48.95 (-0.65%)
NFLX   245.63 (+1.86%)
S&P 500   4,282.47 (+0.20%)
DOW   33,954.79 (-0.08%)
QQQ   330.28 (+0.54%)
AAPL   174.55 (+0.00%)
MSFT   291.53 (+0.07%)
META   175.62 (+0.44%)
GOOGL   120.68 (+0.95%)
AMZN   142.43 (+0.23%)
TSLA   916.90 (+0.54%)
NVDA   188.34 (+2.72%)
NIO   19.98 (-0.50%)
BABA   90.67 (+1.00%)
AMD   100.67 (+2.44%)
MU   63.07 (+2.35%)
T   18.46 (+0.22%)
CGC   3.85 (-5.17%)
F   16.04 (+0.06%)
GE   79.49 (-0.54%)
DIS   122.88 (+0.06%)
AMC   20.04 (-6.18%)
PYPL   99.10 (-0.32%)
PFE   48.95 (-0.65%)
NFLX   245.63 (+1.86%)
S&P 500   4,282.47 (+0.20%)
DOW   33,954.79 (-0.08%)
QQQ   330.28 (+0.54%)
AAPL   174.55 (+0.00%)
MSFT   291.53 (+0.07%)
META   175.62 (+0.44%)
GOOGL   120.68 (+0.95%)
AMZN   142.43 (+0.23%)
TSLA   916.90 (+0.54%)
NVDA   188.34 (+2.72%)
NIO   19.98 (-0.50%)
BABA   90.67 (+1.00%)
AMD   100.67 (+2.44%)
MU   63.07 (+2.35%)
T   18.46 (+0.22%)
CGC   3.85 (-5.17%)
F   16.04 (+0.06%)
GE   79.49 (-0.54%)
DIS   122.88 (+0.06%)
AMC   20.04 (-6.18%)
PYPL   99.10 (-0.32%)
PFE   48.95 (-0.65%)
NFLX   245.63 (+1.86%)
NYSEAMERICAN:EMAN

eMagin - EMAN Stock Forecast, Price & News

$0.81
-0.01 (-1.59%)
(As of 08/18/2022 10:42 AM ET)
Add
Compare
Today's Range
$0.81
$0.82
50-Day Range
N/A
52-Week Range
$0.55
$2.89
Volume
6,200 shs
Average Volume
458,016 shs
Market Capitalization
$62.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

eMagin MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
3.69% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.04mentions of eMagin in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$9,652 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.37 out of 5 stars

EMAN stock logo

About eMagin (NYSEAMERICAN:EMAN) Stock

eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode (OLED) miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. It offers super video graphics array (SVGA) + OLED micro displays; digital SVGA OLED-XL; super extended graphics array OLED-XL/XLS; video graphics array OLED-XL; and widescreen ultra-extended graphics array OLED-XL. The company also provides design reference kits, which include a micro display and associated electronics to help original equipment manufacturers (OEMs) to evaluate micro display products; near-eye virtual imaging modules that incorporate its OLED-on-silicon micro displays with its lenses and electronic interfaces for integration into OEM products; prism optics, a molded plastic prism lens that permits its AMOLED micro displays to provide realistic images that can be viewed for extended periods with reduced eye-fatigue; and driver boards. Its products are used in military aviation helmets, military weapons sights and targeting systems, night vision and thermal imaging devices, training and simulation, visualization for ocular surgery, mobile ultrasound, and augmented reality applications. The company was founded in 1996 and is headquartered in Hopewell Junction, New York.

Receive EMAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for eMagin and its competitors with MarketBeat's FREE daily newsletter.

EMAN Stock News Headlines

eMagin Corporation to Present at IMID 2022
See More Headlines
Receive EMAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for eMagin and its competitors with MarketBeat's FREE daily newsletter.

EMAN Company Calendar

Last Earnings
11/12/2021
Today
8/18/2022
Next Earnings (Estimated)
11/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Semiconductors & related devices
Sub-Industry
N/A
Current Symbol
NYSEAMERICAN:EMAN
Employees
101
Year Founded
N/A

Profitability

Net Income
$-5,210,000.00
Pretax Margin
-19.99%

Debt

Sales & Book Value

Annual Sales
$26.05 million
Book Value
$0.25 per share

Miscellaneous

Free Float
66,455,000
Market Cap
$62.11 million
Optionable
Optionable
Beta
1.62














EMAN Stock - Frequently Asked Questions

How have EMAN shares performed in 2022?

eMagin's stock was trading at $1.18 at the beginning of the year. Since then, EMAN shares have decreased by 30.2% and is now trading at $0.8231.
View the best growth stocks for 2022 here
.

Are investors shorting eMagin?

eMagin saw a drop in short interest in July. As of July 31st, there was short interest totaling 2,540,000 shares, a drop of 6.3% from the July 15th total of 2,710,000 shares. Based on an average daily volume of 412,500 shares, the short-interest ratio is currently 6.2 days. Currently, 3.7% of the shares of the company are sold short.
View eMagin's Short Interest
.

When is eMagin's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our EMAN earnings forecast
.

How were eMagin's earnings last quarter?

eMagin Co. (NYSEAMERICAN:EMAN) announced its quarterly earnings results on Friday, November, 12th. The semiconductor company reported ($0.05) EPS for the quarter. eMagin had a negative trailing twelve-month return on equity of 17.94% and a negative net margin of 28.77%.

What guidance has eMagin issued on next quarter's earnings?

eMagin issued an update on its second quarter 2022 earnings guidance on Friday, July, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $7.00 million-$7.20 million.

What other stocks do shareholders of eMagin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other eMagin investors own include Guyana Goldfields (GUY), Hawkins (HWKN), CA (CA), Kopin (KOPN), Universal Display (OLED), Ampio Pharmaceuticals (AMPE), OPKO Health (OPK), Riot Blockchain (RIOT), BlackRock (BLK) and Advanced Micro Devices (AMD).

What is eMagin's stock symbol?

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

Who are eMagin's major shareholders?

eMagin's stock is owned by a number of institutional and retail investors. Top institutional investors include State Street Corp (0.29%), Jane Street Group LLC (0.19%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Amalkumar Ghosh, Andrew George Sculley Jr, Eric Braddom, Joseph Saltarelli, Ltd Enervest, Ltd Ginola, Mark A Koch, Prache Olivier and Stillwater Holdings Llc.
View institutional ownership trends
.

How do I buy shares of eMagin?

Shares of EMAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is eMagin's stock price today?

One share of EMAN stock can currently be purchased for approximately $0.82.

How much money does eMagin make?

eMagin (NYSEAMERICAN:EMAN) has a market capitalization of $63.12 million and generates $26.05 million in revenue each year. The semiconductor company earns $-5,210,000.00 in net income (profit) each year or ($0.18) on an earnings per share basis.

How many employees does eMagin have?

The company employs 101 workers across the globe.

How can I contact eMagin?

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The official website for the company is www.emagin.com. The semiconductor company can be reached via phone at (845) 838-7900, via email at investorrelations@emagin.com, or via fax at 845-838-7901.

This page (NYSEAMERICAN:EMAN) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.